Kathryn E. Wengel - 25 Mar 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kathryn E. Wengel
Issuer symbol
LH
Transactions as of
25 Mar 2022
Net transactions value
$0
Form type
4
Filing time
29 Mar 2022, 09:47:53 UTC
Previous filing
17 Feb 2022
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +603 603 25 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -603 -45% $0.000000 742 25 Mar 2022 Common Stock 603 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vested fully on March 25, 2022.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.